APA (7th ed.) Citation

Izumi, H., Kodani, M., Kurai, J., Takeda, K., Okazaki, R., Yamane, K., . . . Yamasaki, A. (2019). Nivolumab-induced cholangitis in patients with non-small cell lung cancer: Case series and a review of literature. Molecular & Clinical Oncology, 11(5), 439. https://doi.org/10.3892/mco.2019.1923

Chicago Style (17th ed.) Citation

Izumi, Hiroki, et al. "Nivolumab-induced Cholangitis in Patients with Non-small Cell Lung Cancer: Case Series and a Review of Literature." Molecular & Clinical Oncology 11, no. 5 (2019): 439. https://doi.org/10.3892/mco.2019.1923.

MLA (9th ed.) Citation

Izumi, Hiroki, et al. "Nivolumab-induced Cholangitis in Patients with Non-small Cell Lung Cancer: Case Series and a Review of Literature." Molecular & Clinical Oncology, vol. 11, no. 5, 2019, p. 439, https://doi.org/10.3892/mco.2019.1923.